Myricetin inhibits the proliferation of four colon cancer cell lines by inhibiting the PI3K/Akt/mTOR signaling pathway, which induces cell death and autophagy. Additionally, 3 MA suppresses autophagy, which induces apoptosis in colon cancer cells treated with myricetin. The gene discussed is AKT1; the disease is colonic neoplasm.